Changing treatment-decisions for infantile hemangioma after a decade propanol
Promotor: P.C.M. van de Kerkhof and L.J. Schultze Kool 2018
This thesis provides guidance for this decision-making process, using the data from research in a large cohort of IH-patients. To provide more insight, we looked into the impact of IH on the Quality of Life (QoL) of children and their parents to give direction to treatment indication; we sought for methods to assess the severity of IH in relation to treatment indication; and we brought to light the possible long-term effects of propranolol, to facilitate a deliberate choice about treatment.